BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: den Hollander WJ, Kuipers EJ. Current pharmacotherapy options for gastritis. Expert Opin Pharmacother. 2012;13:2625-2636. [PMID: 23167300 DOI: 10.1517/14656566.2012.747510] [Cited by in Crossref: 22] [Cited by in F6Publishing: 20] [Article Influence: 2.2] [Reference Citation Analysis]
Number Citing Articles
1 Ye JT, Dai YK, Li DY, Zhang YZ, Huang MX, Chen WJ, Li RL, Hu L. Efficacy of Jianpi Liqi therapy for functional dyspepsia: A meta-analysis of randomized, positive medicine-controlled trials. Medicine (Baltimore) 2019;98:e16607. [PMID: 31415353 DOI: 10.1097/MD.0000000000016607] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 0.7] [Reference Citation Analysis]
2 Monteiro CES, Sousa JAO, Lima LM, Barreiro EJ, da Silva-leite KES, de Carvalho CMM, Girão DKFB, Reis Barbosa AL, de Souza MHLP, Gomes Soares PM. LASSBio-596 protects gastric mucosa against the development of ethanol-induced gastric lesions in mice. European Journal of Pharmacology 2019;863:172662. [DOI: 10.1016/j.ejphar.2019.172662] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.7] [Reference Citation Analysis]
3 Yan ZX, Dai YK, Ma T, Lin XY, Chen WH, Liu YM, Zu RZ, Zhang XB, Jiang P, Yang JH, Li S, Zheng LS, Lin ZW. Efficacy of traditional Chinese medicine for chronic gastritis: A meta-analysis of randomized controlled trials. Medicine (Baltimore) 2019;98:e15710. [PMID: 31096520 DOI: 10.1097/MD.0000000000015710] [Cited by in Crossref: 5] [Article Influence: 1.7] [Reference Citation Analysis]
4 Zhang Y, Liu Y, Song R, Zhang L, Su Z, Li Y, Chen R, Shi N, Zhao X, Du S, Ding X. Validating traditional Chinese syndrome features in varied stages of chronic gastritis malignant transformation: study protocol for a cross-sectional study. BMJ Open 2018;8:e020939. [PMID: 30166291 DOI: 10.1136/bmjopen-2017-020939] [Cited by in Crossref: 4] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
5 Yue P, Zhong J, Huang J, Lan Z, Zhong S. The efficacy and safety of Xiangsha Liujunzi decoction in the treatment of chronic non-atrophic gastritis: A protocol for a systematic review and meta-analysis. Medicine (Baltimore) 2021;100:e24504. [PMID: 33530275 DOI: 10.1097/MD.0000000000024504] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
6 Chen HF, Gong Y, Huang Z, Zhao G, Chen ZM, Zen YM, Li HZ, Hu YL. Efficacy and safety of Chinese herbal medicine Qirui Weishu capsule in treating chronic non-atrophic gastritis: A multicentre, double-blind, randomized controlled clinical trial. J Ethnopharmacol 2022;:115341. [PMID: 35551978 DOI: 10.1016/j.jep.2022.115341] [Reference Citation Analysis]
7 Hou D, Yang M, Hu Z, Yang L. Effects of rebamipide for chronic atrophic gastritis: A protocol for systematic review and meta-analysis. Medicine (Baltimore) 2020;99:e20620. [PMID: 32569191 DOI: 10.1097/MD.0000000000020620] [Cited by in Crossref: 1] [Article Influence: 0.5] [Reference Citation Analysis]
8 Liu J, Wang F, Luo H, Liu A, Li K, Li C, Jiang Y. Protective effect of butyrate against ethanol-induced gastric ulcers in mice by promoting the anti-inflammatory, anti-oxidant and mucosal defense mechanisms. International Immunopharmacology 2016;30:179-87. [DOI: 10.1016/j.intimp.2015.11.018] [Cited by in Crossref: 35] [Cited by in F6Publishing: 34] [Article Influence: 5.8] [Reference Citation Analysis]
9 Ping Y, Hu X, Yao Q, Hu Q, Amini S, Miserez A, Tang G. Engineering bioinspired bacteria-adhesive clay nanoparticles with a membrane-disruptive property for the treatment of Helicobacter pylori infection. Nanoscale 2016;8:16486-98. [DOI: 10.1039/c6nr05551f] [Cited by in Crossref: 24] [Cited by in F6Publishing: 5] [Article Influence: 4.0] [Reference Citation Analysis]
10 Li Y, Zhang Y, Meng H, Liao M, Su Z, Zhai M, Jiang L, Li P, Ding X. Efficacy and safety of acupuncture therapy for chronic atrophic gastritis: A meta-analysis and trial sequential analysis protocol. Medicine (Baltimore) 2019;98:e17003. [PMID: 31464956 DOI: 10.1097/MD.0000000000017003] [Cited by in Crossref: 7] [Cited by in F6Publishing: 3] [Article Influence: 2.3] [Reference Citation Analysis]
11 Dai YK, Zhang YZ, Li DY, Ye JT, Zeng LF, Wang Q, Hu L. The efficacy of Jianpi Yiqi therapy for chronic atrophic gastritis: A systematic review and meta-analysis. PLoS One 2017;12:e0181906. [PMID: 28738092 DOI: 10.1371/journal.pone.0181906] [Cited by in Crossref: 14] [Cited by in F6Publishing: 13] [Article Influence: 2.8] [Reference Citation Analysis]
12 Wang FY, Liu JM, Luo HH, Liu AH, Jiang Y. Potential protective effects of Clostridium butyricum on experimental gastric ulcers in mice. World J Gastroenterol 2015; 21(27): 8340-8351 [PMID: 26217085 DOI: 10.3748/wjg.v21.i27.8340] [Cited by in CrossRef: 32] [Cited by in F6Publishing: 30] [Article Influence: 4.6] [Reference Citation Analysis]
13 Zhang J, Huang K, Zhong G, Huang Y, Li S, Qu S, Zhang J. Acupuncture Decreases NF-κB p65, miR-155, and miR-21 and Increases miR-146a Expression in Chronic Atrophic Gastritis Rats. Evid Based Complement Alternat Med 2016;2016:9404629. [PMID: 27293468 DOI: 10.1155/2016/9404629] [Cited by in Crossref: 8] [Cited by in F6Publishing: 12] [Article Influence: 1.3] [Reference Citation Analysis]
14 Lee SE, Song HJ, Park SY, Nam Y, Min CH, Lee DY, Jeong JY, Ha HS, Kim HJ, Whang WK, Jeong JH, Kim IK, Kim HR, Min YS, Sohn UD. Effect of ECQ on Iodoacetamide-Induced Chronic Gastritis in Rats. Korean J Physiol Pharmacol 2013;17:469-77. [PMID: 24227950 DOI: 10.4196/kjpp.2013.17.5.469] [Cited by in Crossref: 6] [Cited by in F6Publishing: 7] [Article Influence: 0.7] [Reference Citation Analysis]
15 Yang L, Hu Z, Zhu J, Fei B. Effects of weifuchun tablet for chronic atrophic gastritis: A protocol for systematic review and meta-analysis. Medicine (Baltimore) 2020;99:e20374. [PMID: 32481421 DOI: 10.1097/MD.0000000000020374] [Reference Citation Analysis]
16 Chen X, Dai Y, Zhang Y, Liu F, Lan S, Wang S, Hu L, Li P. Efficacy of traditional Chinese Medicine for gastric precancerous lesion: A meta-analysis of randomized controlled trials. Complementary Therapies in Clinical Practice 2020;38:101075. [DOI: 10.1016/j.ctcp.2019.101075] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
17 Yang XL, Ju XJ, Mu XT, Wang W, Xie R, Liu Z, Chu LY. Core-Shell Chitosan Microcapsules for Programmed Sequential Drug Release. ACS Appl Mater Interfaces 2016;8:10524-34. [PMID: 27052812 DOI: 10.1021/acsami.6b01277] [Cited by in Crossref: 72] [Cited by in F6Publishing: 51] [Article Influence: 12.0] [Reference Citation Analysis]
18 Yamauchi H, Sakurai S, Nakazawa N, Yoshida T, Tabe Y, Saitoh K, Fukasawa T, Kiriyama S, Naitoh H, Kuwano H. A case of mixed adenoneuroendocrine carcinoma of the stomach with focal intestinal metaplasia and hypergastrinemia. Int Surg 2015;100:562-7. [PMID: 25785345 DOI: 10.9738/INTSURG-D-14-00074.1] [Cited by in Crossref: 10] [Cited by in F6Publishing: 4] [Article Influence: 1.7] [Reference Citation Analysis]
19 Luo C, Sun Z, Li Z, Zheng L, Zhu X. Notoginsenoside R1 (NGR1) Attenuates Chronic Atrophic Gastritis in Rats. Med Sci Monit 2019;25:1177-86. [PMID: 30757999 DOI: 10.12659/MSM.911512] [Cited by in Crossref: 8] [Cited by in F6Publishing: 6] [Article Influence: 2.7] [Reference Citation Analysis]
20 Mao XY, Xu SF, Liu Q, Jiang JX, Zhang HH, Sang HM, Zhang GX. Anatomical predilection of intestinal metaplasia based on 78,335 endoscopic cases. Saudi J Gastroenterol 2016;22:154-60. [PMID: 26997223 DOI: 10.4103/1319-3767.178528] [Cited by in F6Publishing: 3] [Reference Citation Analysis]
21 Peppelenbosch MP, Frijns N, Fuhler G. Systems medicine approaches for peptide array-based protein kinase profiling: progress and prospects. Expert Rev Proteomics 2016;13:571-8. [PMID: 27241729 DOI: 10.1080/14789450.2016.1187564] [Cited by in Crossref: 9] [Cited by in F6Publishing: 8] [Article Influence: 1.5] [Reference Citation Analysis]